On the Horizon: New Expression Systems to Become Common Industry Platforms
New, alternative expression systems in various stages of development are showing their viability in large-scale protein manufacture. So, the question is no longer if an alternative platform will emerge, but which of the more than 340 expressions systems and associated genetic engineering technologies available for licensing will become the next common industry platform. In any case, it's very likely that the industry will be seeing broader diversity in the expression systems used at the commercial level over the next five years. [more...]
|
|
|
